Ignite Creation Date:
2024-05-06 @ 6:34 PM
Last Modification Date:
2024-10-26 @ 2:50 PM
Study NCT ID:
NCT05704647
Status:
RECRUITING
Last Update Posted:
2024-06-17
First Post:
2023-01-19
Brief Title:
Phase II Study of Nivolumab in Combination With Relatlimab in Patients With Active Melanoma Brain Metastases
Sponsor:
Organization:
MD Anderson Cancer Center